A Study of Lebrikizumab in Patients With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and A Second Controller Medication (VERSE)

NCT01545453 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

205

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: lebrikizumab
DRUG: lebrikizumab
DRUG: lebrikizumab
DRUG: placebo

Sponsor

Genentech, Inc.